Today: 7 February 2026
Subscribe
Browse Category

Investment Analysis News 12 January 2026 - 13 January 2026

Confluent scraps earnings call ahead of IBM takeover — what it means for CFLT stock

Confluent scraps earnings call ahead of IBM takeover — what it means for CFLT stock

NEW YORK, Jan 13, 2026, 02:45 EST Confluent (CFLT.O) said on Monday it will report fourth-quarter and full-year 2025 results on Feb. 11, but it will not hold an earnings conference call or provide a financial outlook because of its pending sale to IBM (IBM.N). https://www.businesswire.com/news/home/20260112152645/en/Confluent-to-Announce-Fourth-Quarter-and-Fiscal-Year-2025-Financial-Results-on-February-11-2026 That matters now because earnings calls are usually where management answers the only question deal traders keep asking: is anything slowing down. With no call, the stock loses one of its few near-term pressure points. The absence of guidance also keeps the focus on timing and odds, not the quarter itself. For a cash
13 January 2026
·····
Oklo stock slips as insiders sell shares and traders reassess Meta nuclear deal

Oklo stock slips as insiders sell shares and traders reassess Meta nuclear deal

New York, Jan 12, 2026, 20:56 EST — Market closed. Oklo Inc (OKLO) shares fell 2.7% on Monday to close at $102.50, paring a run that has taken the stock up about 43% since the end of 2025. The pullback followed Friday’s jump, when the stock swung as high as $115.72 after news tied it more closely to Meta Platforms’ push to lock in nuclear power for data centers. (Investing.com) The move matters because Oklo has become one of the market’s higher-beta ways to trade the “AI power demand” theme. Meta said on Friday it struck 20-year agreements to buy
13 January 2026
·····
GE Aerospace stock heads into earnings week as Airbus flags engine delays and brokers tweak targets

GE Aerospace stock heads into earnings week as Airbus flags engine delays and brokers tweak targets

NEW YORK, Jan 12, 2026, 8:14 PM EST — Market closed GE Aerospace (GE) shares closed Monday at $324.17, up 0.8%, following Wolfe Research’s update. The firm lifted its price target to $360 from $340 and kept its Outperform rating. (MarketScreener) U.S. markets were closed Monday, shifting focus as stocks head into Tuesday toward a familiar issue: can jetmakers secure enough engines and parts to maintain their assembly lines? GE’s earnings report next week has traders watching supply chain updates closely, keeping aerospace stocks in the spotlight. Airbus voiced worries Monday over engine deliveries from Pratt & Whitney, owned by
13 January 2026
·······
Alnylam stock sinks nearly 7% after Amvuttra revenue miss; what to watch next for ALNY

Alnylam stock sinks nearly 7% after Amvuttra revenue miss; what to watch next for ALNY

New York, Jan 12, 2026, 20:02 EST — Market closed Alnylam Pharmaceuticals’ shares fell sharply on Monday after the drugmaker’s preliminary fourth-quarter sales for its flagship heart drug Amvuttra came in below Wall Street expectations. The decline hit as investors digested the company’s new five-year strategy and 2026 revenue outlook, rolled out around the J.P. Morgan Healthcare Conference in San Francisco. Why it matters now: early-January “preannouncements” can reset the bar ahead of earnings season, and Amvuttra has become Alnylam’s core growth driver. A small miss on that product can outweigh upbeat long-range targets, at least for a session or
13 January 2026
·····
Exxon stock slips after Trump hints at Venezuela block — what to watch before Tuesday

Exxon stock slips after Trump hints at Venezuela block — what to watch before Tuesday

New York, Jan 12, 2026, 18:53 EST — After-hours Exxon Mobil shares slipped in after-hours trading Monday following President Donald Trump’s comment that he might block the oil giant from Venezuela’s reopening—a rare public rebuke aimed at the company’s CEO. This episode is crucial as Washington moves fast to redirect Venezuela’s oil shipments following last week’s power shift in Caracas. Investors are scrambling to figure out which producers could tap into those barrels—and on what terms. Exxon investors now face an extra political risk on top of an already volatile oil market. Moves benefiting Venezuela’s competitors might not shift the
13 January 2026
····
Micron stock holds near a fresh high as suppliers lift chip testing fees; what comes next

Micron stock holds near a fresh high as suppliers lift chip testing fees; what comes next

New York, Jan 12, 2026, 16:47 ET — After-hours Micron Technology shares ended slightly higher on Monday and were little changed in after-hours trading after a report said memory-chip testing and packaging vendors have raised prices by as much as 30%, adding another pressure point in a tight supply chain. The stock closed at $345.87, up 0.2%, after touching a session high that matched its 52-week peak. (Investing.com) The fee hikes matter because outsourced assembly and test, known as OSAT, is the packaging and checking step that comes after chips are made — and it can turn into a bottleneck
12 January 2026
·····
Alnylam stock slides after “Alnylam 2030” plan, Amvuttra Q4 sales come up short

Alnylam stock slides after “Alnylam 2030” plan, Amvuttra Q4 sales come up short

New York, Jan 12, 2026, 16:34 (EST) — After-hours Alnylam Pharmaceuticals shares dropped in late Monday trading after the RNA interference drugmaker unveiled a new five-year plan and provided early 2026 sales guidance, along with preliminary figures for 2025. The stock slipped roughly 6.7% to $370.91. The company unveiled its “Alnylam 2030” initiative, aiming for “leadership in ATTR amyloidosis” and “sustained, profitable growth.” It’s targeting total revenue compound annual growth above 25% through 2030, along with a non-GAAP operating margin near 30%. For 2026, combined net product revenue is expected between $4.9 billion and $5.3 billion, spanning AMVUTTRA, ONPATTRO, GIVLAARI,
12 January 2026
·····
Arcutis Biotherapeutics stock slides after 2026 ZORYVE sales outlook; June FDA deadline in focus

Arcutis Biotherapeutics stock slides after 2026 ZORYVE sales outlook; June FDA deadline in focus

New York, January 12, 2026, 15:41 ET — Regular session Shares of Arcutis Biotherapeutics dropped 8.7% on Monday, slipping $2.46 to $25.76, following the company’s update on its 2026 priorities. The dermatology drugmaker set a $455 million to $470 million target for net product sales in its ZORYVE franchise. The stock hit a session low of $25.51 during trading. The message is crucial as Arcutis hits a stage where investors demand more than just rapid script growth — they want evidence it can scale without another cash drain. One marketed franchise can sustain a company, until it can’t. It also
12 January 2026
·····
HealthEquity stock slides nearly 10% after 2027 outlook; JPM conference is next test

HealthEquity stock slides nearly 10% after 2027 outlook; JPM conference is next test

New York, Jan 12, 2026, 15:31 EST — Regular session Shares of HealthEquity dropped roughly 10% in Monday afternoon trading following the benefits administrator’s cautious initial fiscal 2027 outlook. The stock last traded down $9.53 at $84.62, hitting a session low around $84.51. This move is significant since HealthEquity’s longer-term targets often set the valuation benchmark for HSA custodians, whose earnings can fluctuate with interest rates and cash yields. Investors have a tight window to process this: the company is slated to present at the J.P. Morgan Healthcare Conference on Tuesday. Traders are locked in on the 2026 trajectory for
12 January 2026
····
Texas Instruments stock slips as chip ETF firms; investors eye Jan. 27 earnings amid Fed jitters

Texas Instruments stock slips as chip ETF firms; investors eye Jan. 27 earnings amid Fed jitters

New York, Jan 12, 2026, 15:11 EST — Regular session. Texas Instruments shares slipped slightly on Monday afternoon, lagging behind the steadier semiconductor sector. The stock dipped roughly 0.2% to $189.85. The split matters since Texas Instruments serves as a bellwether for analog chips — those crucial components inside factory equipment, cars, and common electronics. With its next update looming, positioning is already shifting. Macro noise isn’t doing any favors. A Justice Department probe touching Federal Reserve Chair Jerome Powell, plus the political fallout, has stirred up fresh doubts over Fed independence, rattling both rates and currency markets. https://www.reuters.com/business/investors-anxious-over-make-or-break-fight-fed-2026-01-12/ Markets
12 January 2026
·····
Honeywell stock flat as new Google Cloud retail tech lands, Citi trims target ahead of earnings

Honeywell stock flat as new Google Cloud retail tech lands, Citi trims target ahead of earnings

New York, Jan 12, 2026, 15:00 EST — Regular session Shares of Honeywell International Inc (HON.O) ticked up roughly 0.1% to $207.5 in Monday afternoon trading, as investors digested the company’s latest product launches targeting retailers and warehouse operators. The timing is crucial as Honeywell prepares to release its fourth-quarter results and 2026 outlook on Jan. 29. Investors will be watching to see if its automation efforts are translating into more consistent growth and improved margins. (Honeywell) The industrial conglomerate kicks off 2026 with a revamped reporting structure, spotlighting Aerospace Technologies, Building Automation, Industrial Automation, and Process Automation and Technology
12 January 2026
·····
Verizon stock slips in regular trade as ex-dividend date hits, earnings loom

Verizon stock slips in regular trade as ex-dividend date hits, earnings loom

New York, Jan 12, 2026, 14:22 EST — Regular session Verizon Communications Inc shares slipped 1.6% to $39.81 by Monday afternoon, following a Friday close of $40.46. During the session, the stock fluctuated between $39.52 and $40.08, with roughly 18.7 million shares traded. The drop follows Verizon’s ex-dividend date, when shares begin trading without the upcoming dividend entitlement. According to Verizon’s investor site, the quarterly dividend is $0.69 per share, with both the ex-dividend and record dates on Jan. 12, and a payment date of Feb. 2. Yahoo Finance shows a forward dividend of $2.76 per share, signaling a yield
12 January 2026
····
1 … 53 54 55 56 57 … 282

Stock Market Today

Seagate (STX) stock jumps nearly 6% as Citi hikes target — what to watch next week

Seagate (STX) stock jumps nearly 6% as Citi hikes target — what to watch next week

7 February 2026
Seagate shares rose 5.9% to $429.32 Friday after Citigroup raised its price target to $480 and reiterated a buy rating. The gain ended a two-day slide but left the stock 6.6% below its Feb. 3 high. CEO Dave Mosley sold 20,000 shares on Feb. 2 under a pre-arranged plan, SEC filings show. U.S. jobs and inflation data next week are seen as key tests for tech stocks.
Cummins (CMI) stock price rebounds after earnings whipsaw as investors eye data-center power demand

Cummins (CMI) stock price rebounds after earnings whipsaw as investors eye data-center power demand

7 February 2026
Cummins shares jumped 6.8% to $577.73 Friday, recovering from a nearly 9% post-earnings drop the day before. The company reported Q4 revenue up 1% to $8.54 billion, took a $218 million charge tied to its hydrogen business, and guided for 2026 EBITDA of 17–18% of sales. Demand for data center generators offset weakness in North American truck markets. Analyst reaction was mixed; Truist raised its price target.
Corning stock hits first record close since 2000 as jobs, CPI data loom

Corning stock hits first record close since 2000 as jobs, CPI data loom

7 February 2026
Corning shares surged 8.3% to $122.16 Friday, their highest close since the dot-com era, after Meta agreed to buy up to $6 billion in fiber-optic cables. The stock is up 40% since late 2025, fueled by strong first-quarter guidance and AI data-center demand. Insiders sold shares following the rally, SEC filings show. Investors await next week’s U.S. jobs and inflation data for rate signals.
Go toTop